Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

NCT02220673 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BHT 0.1%
DRUG: BHT 0.5%
DRUG: Placebo for RMT-B
DRUG: Placebo for HFA-MDI

Sponsor

Boehringer Ingelheim